$MediWound (MDWD.US)$Reuters ·3 mins ago Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
$MediWound (MDWD.US)$MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army 1 MINUTE AGO, 7:00 AM EST VIA GLOBENEWSWIRE
MediWound's high P/S ratio and weaker growth forecast compared to the wider industry could worry investors. Without significant business improvement, the stock price may face a drop risk.
MediWound股票討論
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
暫無評論